Antiviral agents that act in the early phases of the viral cycle

The development of antiviral chemotherapy against human immunodeficiency virus (HIV) and herpesvirus suffers from two main problems: the toxic side effects and the emergence of drug resistance associated to the continuous treatment of immunocompromised patients. A variety of compounds targeted at th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Damonte, E.B.
Formato: JOUR
Materias:
HIV
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_03257541_v28_n4_p204_Damonte
Aporte de:

Ejemplares similares